Potential Medicare Part D Savings on Ophthalmic Generic Drugs

被引：3
|
作者：
Collet, David A. [1 ]
Urban, Matthew B. [1 ]
Amin, Abha [2 ]
机构：
[1] New York Med Coll, Sch Med, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Dept Ophthalmol, Valhalla, NY USA
来源：
JAMA OPHTHALMOLOGY | 2024年 / 142卷 / 07期
关键词：
D O I：
10.1001/jamaophthalmol.2024.1717
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
This economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.
引用
收藏
页码：678 / 680
页数：3
相关论文
共 50 条
  • [41] The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use
    James X. Zhang
    Wesley Yin
    Shawn X. Sun
    G. Caleb Alexander
    Journal of General Internal Medicine, 2008, 23 : 1673 - 1678
  • [42] Generic Initiation and Antidepressant Therapy Adherence Under Medicare Part D
    Bao, Yuhua
    Ryan, Andrew M.
    Shao, Huibo
    Pincus, Harold Alan
    Donohue, Julie M.
    AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (12): : 989 - 998
  • [43] The impact of the Medicare Part D prescription benefit on generic drug use
    Zhang, James X.
    Yin, Wesley
    Sun, Shawn X.
    Alexander, G. Caleb
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (10) : 1673 - 1678
  • [44] Increasing generic drug use in medicare part D: The role of government
    Kohl, Herb
    Shrank, William H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (07) : 1106 - 1109
  • [45] EXCESSIVE SPENDING ON BRAND-NAME COMBINATION DRUGS MADE FROM INEXPENSIVE GENERIC COMPONENTS IN MEDICARE PART D
    Sacks, Chana A.
    Lee, ChangWon C.
    Kesselheim, Aaron
    Avorn, Jerry
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S190 - S190
  • [46] Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit
    Fischer, MA
    Avorn, J
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (04) : 207 - 214
  • [47] Estimating Discounts for Top Spending Drugs in Medicare Part D
    Hernandez, Inmaculada
    San-Juan-Rodriguez, Alvaro
    Good, Chester B.
    Gellad, Walid F.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (08) : 2503 - 2505
  • [48] The influence of Medicare Part D on the list pricing of brand drugs
    Ippolito, Benedic N.
    Levy, Joseph F.
    HEALTH SERVICES RESEARCH, 2023, 58 (04) : 948 - 952
  • [49] Estimating Discounts for Top Spending Drugs in Medicare Part D
    Inmaculada Hernandez
    Alvaro San-Juan-Rodriguez
    Chester B. Good
    Walid F. Gellad
    Journal of General Internal Medicine, 2021, 36 : 2503 - 2505
  • [50] Will Part D produce savings in Part A and Part B? The impact of prescription drug coverage on Medicare program expenditures
    Stuart, Bruce C.
    Briesacher, Becky A.
    Doshi, Jalpa A.
    Wrobel, Marian V.
    Baysac, Fatima
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2007, 44 (02) : 146 - 156
12345